Status: Recruiting
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health.
Participants needed: 112
Trial details
Phase: Phase 1Age: 18-50Biological sex: AllType: InterventionalSponsor: International AIDS Vaccine InitiativeUpdated: Jun 18, 2026Locations: 3
Eligibility criteria
Adults in good general health [+8]
Any clinically significant acute or chronic medical condition that is considered... [+15]